Fukuang General Hospital of Liaoning Health Industry Group Trials

Fukuang General Hospital of Liaoning Health Industry Group	Welcome, Profile Billing Logout

64 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Zhang, Hong

NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Recruiting

477

RoW

transanal surgery, Miles surgery, Preoperative chemoradiotherapy

Zhang Rui

Almost-cCR, Surgery, Rectal Cancer

01/20

12/22

CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed

1412

RoW

Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA

Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital

Acute Ischemic Stroke

06/23

NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed

163

RoW

Lotilaner, TP-03, S-Misoxam, Vehicle Control

LianBio LLC

Blepharitis

09/23

04/24

NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Recruiting

1630

RoW

Alteplase, rt-PA, Tenecteplase, TNK-tPA

Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd

Acute Ischemic Stroke

11/23

03/24

TQC2731-III-01, NCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Recruiting

660

RoW

TQC2731 injection, Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Asthma

06/27

TaLaR-02, NCT05984485: The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

Recruiting

766

RoW

neoadjuvant chemotherapy plus total mesorectal excision, total mesorectal excision

Sun Yat-sen University

Rectal Cancer

07/28

NCT05702489: A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Completed

2/3

900

RoW

ZX-7101A

Nanjing Zenshine Pharmaceuticals

Influenza, Human

05/23

10/23

NCT06137768: A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Active, not recruiting

123

RoW

HRS-5965, Placebo

Chengdu Suncadia Medicine Co., Ltd.

Primary IgA Nephropathy

12/24

08/25

NCT04398459: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Active, not recruiting

RoW

Ibrutinib, BTK inhibitor

Institute of Hematology & Blood Diseases Hospital, China

Refractory/Relapsed Autoimmune Hemolytic Anemia

12/24

06/25

NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Terminated

RoW

TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Chronic Obstructive Pulmonary Disease (COPD)

01/23

12/23

NCT06670352: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Recruiting

RoW

Placebo, HSK39297 50mgBID, HSK39297 100mgBID, HSK39297 200mgQD

Haisco Pharmaceutical Group Co., Ltd.

IgA Nephropathy (IgAN)

11/25

03/26

BID-PERAL, NCT04423367: Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Completed

RoW

bortezomib/dexamethasone

Institute of Hematology & Blood Diseases Hospital, China

Acquired Pure Red Cell Aplasia

07/24

09/24

NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Completed

RoW

Herombopag, Cyclosporine A

Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Non Severe Aplastic Anemia, Untreated

01/25

NCT06687174: Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Not yet recruiting

RoW

MY008211A tablets, MY008211A tablets matched placebo

Wuhan Createrna Science and Technology Co., Ltd

IgA Nephropathy (IgAN)

06/26

01/28

NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Recruiting

168

RoW

TQH2722 injection, TQH2722 Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Seasonal Allergic Rhinitis

06/25

08/25

NCT04688736: Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Recruiting

6642

RoW

Placebo, Chlorpheniramine

Institute of Hematology & Blood Diseases Hospital, China

Allergic Transfusion Reaction

12/25

06/26

NCT06774664: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

Not yet recruiting

1/2

RoW

SCTC21C

Sinocelltech Ltd.

IgA Nephropathy

09/27

03/29

NCT04481841: Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Recruiting

290

RoW

oryzanol + vitamin B2 (riboflavin) + vitamin E, head yuanshi dian therapy

Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Hospital of TCM, Guiyang Hospital of Stomatology

Burning Mouth Syndrome, Oral Mucosa Disease

02/22

05/22

NCT06101316: A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

Recruiting

RoW

CB06-036

Shanghai Zhimeng Biopharma, Inc.

Healthy Volunteers

10/23

12/23

NCT06216041: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Recruiting

138

RoW

IMM-H014, Placebo, IMM-H014 ( FE), Placebo ( FE)

Changchun Intellicrown Pharmaceutical Co. LTD

Nonalcoholic Steatohepatitis (NASH)

06/25

08/25

NCT06160895: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Completed

RoW

TQ-A3334 tablets, TQ-A3334 placebo tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Hepatitis B

06/24

08/24

NCT06427681: An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Not yet recruiting

BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection, EMEND®+PALONOSETRON

Zhuhai Beihai Biotech Co., Ltd

Bioavailability

09/24

12/24

AP303-PK-03, NCT06666283: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Not yet recruiting

AP303 150μg, AP303 300μg, Placebo 150μg, Placebo 300μg

Alebund Pharmaceuticals

Diabetic Kidney Disease

01/25

NCT06895993: Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants

Not yet recruiting

RoW

Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Injectafer®]

Sichuan Huiyu Pharmaceutical Co., Ltd, Suzhou Guochen Biotechnology Co., Ltd., Guangzhou Jeeyor Medical Research Co.,Ltd., Boji Medical Technology Co., Ltd., The First Hospital of Jilin University

Healthy Adult

04/25

05/25

NCT03806621: Rota China Registry

Completed

N/A

980

RoW

Rotational Atherectomy

Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd.

Coronary Artery Disease

12/20

01/22

UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting

N/A

200

RoW

Drug eluting Balloon

Zhejiang Zylox Medical Device Co., Ltd.

Peripheral Arterial Disease (PAD)

12/22

12/24

NCT05608980: 0.01% Hypochlorous Acid in the Treatment of Blepharitis

Recruiting

N/A

100

RoW

0.01% hypochlorous acid, 0.01%HOCI, Placebo

Eye & ENT Hospital of Fudan University, ShuGuang Hospital

Blepharitis

12/22

05/23

NCT05685966: Retrospective Study of COVID-19 on Reproductive Function

Recruiting

N/A

400

RoW

no intervention

Jinling Hospital, China

COVID-19

03/23

01/24

NCT04852406: Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Recruiting

N/A

526

RoW

Protocol-based management of perioperative antithrombotic therapy, Protocol-based management, Routine management of perioperative antithrombotic therapy, Routine management

Peking University First Hospital

Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes

12/23

01/24

NCT05685992: Novel Coronavirus Infection and Reproductive Function

Recruiting

N/A

400

RoW

no intervention

Jinling Hospital, China

COVID-19 Infection

01/24

CSILS, NCT04527861: Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Recruiting

N/A

710

RoW

Single-incision Laparoscopic Surgery, SILS, Conventional Laparoscopic Surgery, CLS

Ruijin Hospital, Dongfang Hospital Affiliated to Tongji University, Fudan University, Changhai Hospital, Shengjing Hospital, RenJi Hospital, Liaoning Cancer Hospital & Institute, Zhejiang Provincial People's Hospital, Shandong Provincial Hospital, The General Hospital of Western Theater Command, Shanghai Jiao Tong University School of Medicine

Colorectal Cancer, Colon Cancer, Rectal Cancer

04/24

04/29

NCT04645810: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Recruiting

N/A

High-Dose-Rate Brachytherapy

University of Rochester

Prostate Cancer, HDR

05/26

05/27

SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis

Recruiting

N/A

328

RoW

Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon

DK Medical Technology (Suzhou) Co., Ltd.

Arteriovenous Fistula Stenosis

07/27

TaLaR, NCT02966483: Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Recruiting

N/A

1114

RoW

TaTME, Transanal TME, LpTME, Laparoscopic TME

Sun Yat-sen University, Peking Union Medical College Hospital, The First Hospital of Jilin University, RenJi Hospital, Shengjing Hospital, The Second People's Hospital of Yibin, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Nanchong Central Hospital, Zunyi Medical College, The First Affiliated Hospital of University of South China, Xinqiao Hospital, Nanfang Hospital, Southern Medical University, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, Affiliated Hospital of Guangdong Medical University, The Third Xiangya Hospital of Central South University

Rectal Neoplasms Malignant, Surgery

07/26

mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting

N/A

10000

RoW

Installation or registration of smartphone application

Chinese Alliance Against Lung Cancer

Solitary Pulmonary Nodule

10/25

NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting

N/A

2150

RoW

Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy

Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Heart Disease

01/26

01/28

FLORA-01, NCT05730595: Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Not yet recruiting

N/A

550

RoW

lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University, Fujian Province Tumor Hospital, Guangdong Provincial People's Hospital, Shengjing Hospital, Affiliated Hospital of Qinghai University, Hebei Medical University Fourth Hospital, The Second Affiliated Hospital of Harbin Medical University, Jiangxi Provincial Cancer Hospital, The First Hospital of Jilin University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, Nanfang Hospital, Southern Medical University, Second People's Hospital of Yunnan Province, Binzhou Medical University, The First Affiliated Hospital of University of Science and Technology of China, First Affiliated Hospital of Chengdu Medical College, The Second People's Hospital of Yibin, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Colorectal Neoplasms, Fluorescence, Lymph Node Excision

12/26

06/27

TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting

N/A

366

Canada, RoW

The George Institute, Peking University Institute of Nephrology

IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases

07/27

coordinator

NCT05070455: An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Recruiting

Asceniv™

ADMA Biologics, Inc.

Primary Immune Deficiency

03/23

06/23

NCT06923891: An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients

Not yet recruiting

172

Xanomeline/Trospium, Cobenfy

Vanguard Research Group, Bristol-Myers Squibb

Schizophrenia

10/26

11/26

VRDN-001-302, NCT06179875: An Open-label Study for Non-responders of VRDN-001-101 and VRDN-001-301 (OLE)

Active, not recruiting

143

Europe, US, RoW

Intervention/Treatment

Viridian Therapeutics, Inc.

Thyroid Eye Disease

05/25

07/25

RECOVER, NCT05184335: Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Recruiting

690

Brilaroxazine, RP5063, Placebo

Reviva Pharmaceuticals

Schizophrenia

02/25

STRIVE, NCT06384547: A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants with Thyroid Eye Disease (TED)

Active, not recruiting

231

Europe, US, RoW

VRDN-001 10 mg/kg, VRDN-001 3 mg/kg

Viridian Therapeutics, Inc.

Thyroid Eye Disease

05/25

01/26

REVEAL-1, NCT06625411: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Active Thyroid Eye Disease (TED)

Recruiting

117

VRDN-003, Placebo

Viridian Therapeutics, Inc.

Thyroid Eye Disease

03/26

11/26

REVEAL-2, NCT06625398: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Chronic Thyroid Eye Disease (TED)

Recruiting

195

VRDN-003, Placebo

Viridian Therapeutics, Inc.

Thyroid Eye Disease

04/26

12/26

THRIVE-2, NCT06021054: An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Active, not recruiting

188

Europe, US, RoW

Veligrotug (VRDN-001), Placebo

Viridian Therapeutics, Inc.

Thyroid Eye Disease

12/24

08/25

NCT04222062: A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Recruiting

100

Carmustine 7.7Mg Wafer, GLIADEL

University of Nebraska, Arbor Pharmaceuticals, Inc.

Brain Tumor - Metastatic

12/27

12/28

NCT06107686: A Study of YL202 in Selected Patients with Advanced Solid Tumors

Recruiting

200

RoW

YL202 should be intravenously infused

MediLink Therapeutics (Suzhou) Co., Ltd.

NSCLC, Breast Cancer, HNSCC, Locally Advanced or Metastatic Solid Tumors

11/26

11/28

NCT06057922: A Study YL201 in Patients With Selected Advanced Solid Tumors

Recruiting

1/2

990

RoW

YL201 for Injection

MediLink Therapeutics (Suzhou) Co., Ltd.

Advanced Solid Tumor

10/26

10/28

BLAAC PD, NCT06719583: Black and African Americans Connections to Parkinson's Disease

Recruiting

N/A

2000

Michael J. Fox Foundation for Parkinson's Research, National Institutes of Health (NIH), University of Chicago, University of Alabama at Birmingham, Rush University, Washington University School of Medicine, Medical University of South Carolina, University Hospitals Cleveland Medical Center, Louisiana State University Health Sciences Center Shreveport, University of Florida, University of Maryland, The University of Texas Health Science Center, Houston, Ochsner Health System

Parkinson Disease

12/26

NCT06186596: Self-Administered Intralesional Injections for Acne

Recruiting

N/A

150

Triamcinolone delivered via injection assistance device

ACOM Labs

Acne Vulgaris

01/24

NCT05879198: Train Your Brain: A Pilot Project to Improve Memory and Decision Making

Completed

N/A

Computer-based Intervention

Henry Ford Health System, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Behavior, Health

09/23

PRIMA-102, NCT05936970: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD

Recruiting

N/A

1410

Aqtual, Inc.

Rheumatoid Arthritis

06/25

12/25

NCT04642898: Increasing Treatment Efficacy Using SMART Methods for Personalizing Care

Completed

N/A

Standard UP Treatment, Capitalization UP Treatment, Compensation UP Treatment

Shannon E. Sauer-Zavala, National Institute of Mental Health (NIMH)

Anxiety Disorders, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder

06/24

NCT03594994: Metabolic Effects of Sleep Extension in People With Obesity

Completed

N/A

Sleep extension

Washington University School of Medicine

Insulin Resistance, Obesity

07/24

NCT06242704: Train Your Brain 2.0 - Improving Memory and Decision Making Among Youth

Recruiting

N/A

Working Memory Training, Working Memory

Henry Ford Health System

Behavior, Health

08/26

NCT04587518: Five Factor Model Treatment for Borderline Personality Disorder

Completed

N/A

100

Personality-Based Cognitive Behavioral Therapy

Shannon E. Sauer-Zavala

Borderline Personality Disorder

05/24

NCT05100836: SURPASS Impella 5.5 Study

Active, not recruiting

N/A

1017

Impella 5.5

Abiomed Inc.

Cardiogenic Shock, Acute Decompensated Heart Failure

03/25

ELEVATE-HF, NCT06592508: Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure

Recruiting

N/A

180

Remote Virtual Cardiology Program

Duke University, Ventricle Health

Heart Failure; With Decompensation

08/26

NCT03701828: Liver Health and Metabolic Function in People With Obesity

Completed

N/A

Weight loss surgery, Sleeve gastrectomy, Roux-en-Y, biliopancreatic diversion

Washington University School of Medicine

Non-Alcoholic Fatty Liver Disease

02/24

PsOWell, NCT05631223: Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)

Recruiting

N/A

Telemedicine

University of Pennsylvania

Psoriatic Arthritis

12/25

EIR, NCT05489133: Early Psychological Intervention After Rape

Recruiting

N/A

200

Europe

Modified prolonged exposure, Brief intervention, cognitive behavioral therapy

St. Olavs Hospital, Norwegian University of Science and Technology, The Research Council of Norway, Norwegian Women's Public Health Association (Norske Kvinners Sanitetsforening), National Centre for Emergency Primary Health Care, NORCE, UiT The Arctic University of Norway

Post Traumatic Stress Disorder, Rape Sexual Assault, Sexual Dysfunctions, Psychological, Pelvic Floor Myalgia, Pelvic Pain Syndrome, Depression, Anxiety, Sleep Disturbance, Activity, Motor, Cortisol Deficiency

05/25

12/27

CHOICES3, NCT05292781: Sickle Cell Disease Parenting CHOICES

Recruiting

N/A

506

CHOICES, eBook

University of Florida, National Human Genome Research Institute (NHGRI)

Sickle Cell Disease, Sickle Cell Trait

06/25

EXTEND, NCT05120544: Expanding Technology-Enabled Nurse Delivered Chronic Disease Care

Active, not recruiting

N/A

220

EXTEND Plus, EXTEND

Duke University, National Institute of Nursing Research (NINR)

Diabetes Mellitus, Type 2, Hypertension

10/25

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Zhang, Hong

NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Recruiting

477

RoW

transanal surgery, Miles surgery, Preoperative chemoradiotherapy

Zhang Rui

Almost-cCR, Surgery, Rectal Cancer

01/20

12/22

CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed

1412

RoW

Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA

Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital

Acute Ischemic Stroke

06/23

NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed

163

RoW

Lotilaner, TP-03, S-Misoxam, Vehicle Control

LianBio LLC

Blepharitis

09/23

04/24

NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Recruiting

1630

RoW

Alteplase, rt-PA, Tenecteplase, TNK-tPA

Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd

Acute Ischemic Stroke

11/23

03/24

TQC2731-III-01, NCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Recruiting

660

RoW

TQC2731 injection, Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Asthma

06/27

TaLaR-02, NCT05984485: The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

Recruiting

766

RoW

neoadjuvant chemotherapy plus total mesorectal excision, total mesorectal excision

Sun Yat-sen University

Rectal Cancer

07/28

NCT05702489: A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Completed

2/3

900

RoW

ZX-7101A

Nanjing Zenshine Pharmaceuticals

Influenza, Human

05/23

10/23

NCT06137768: A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Active, not recruiting

123

RoW

HRS-5965, Placebo

Chengdu Suncadia Medicine Co., Ltd.

Primary IgA Nephropathy

12/24

08/25

NCT04398459: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Active, not recruiting

RoW

Ibrutinib, BTK inhibitor

Institute of Hematology & Blood Diseases Hospital, China

Refractory/Relapsed Autoimmune Hemolytic Anemia

12/24

06/25

NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Terminated

RoW

TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Chronic Obstructive Pulmonary Disease (COPD)

01/23

12/23

NCT06670352: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Recruiting

RoW

Placebo, HSK39297 50mgBID, HSK39297 100mgBID, HSK39297 200mgQD

Haisco Pharmaceutical Group Co., Ltd.

IgA Nephropathy (IgAN)

11/25

03/26

BID-PERAL, NCT04423367: Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Completed

RoW

bortezomib/dexamethasone

Institute of Hematology & Blood Diseases Hospital, China

Acquired Pure Red Cell Aplasia

07/24

09/24

NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Completed

RoW

Herombopag, Cyclosporine A

Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Non Severe Aplastic Anemia, Untreated

01/25

NCT06687174: Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Not yet recruiting

RoW

MY008211A tablets, MY008211A tablets matched placebo

Wuhan Createrna Science and Technology Co., Ltd

IgA Nephropathy (IgAN)

06/26

01/28

NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Recruiting

168

RoW

TQH2722 injection, TQH2722 Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Seasonal Allergic Rhinitis

06/25

08/25

NCT04688736: Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Recruiting

6642

RoW

Placebo, Chlorpheniramine

Institute of Hematology & Blood Diseases Hospital, China

Allergic Transfusion Reaction

12/25

06/26

NCT06774664: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

Not yet recruiting

1/2

RoW

SCTC21C

Sinocelltech Ltd.

IgA Nephropathy

09/27

03/29

NCT04481841: Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Recruiting

290

RoW

oryzanol + vitamin B2 (riboflavin) + vitamin E, head yuanshi dian therapy

Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Hospital of TCM, Guiyang Hospital of Stomatology

Burning Mouth Syndrome, Oral Mucosa Disease

02/22

05/22

NCT06101316: A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

Recruiting

RoW

CB06-036

Shanghai Zhimeng Biopharma, Inc.

Healthy Volunteers

10/23

12/23

NCT06216041: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Recruiting

138

RoW

IMM-H014, Placebo, IMM-H014 ( FE), Placebo ( FE)

Changchun Intellicrown Pharmaceutical Co. LTD

Nonalcoholic Steatohepatitis (NASH)

06/25

08/25

NCT06160895: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Completed

RoW

TQ-A3334 tablets, TQ-A3334 placebo tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Hepatitis B

06/24

08/24

NCT06427681: An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Not yet recruiting

BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection, EMEND®+PALONOSETRON

Zhuhai Beihai Biotech Co., Ltd

Bioavailability

09/24

12/24

AP303-PK-03, NCT06666283: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Not yet recruiting

AP303 150μg, AP303 300μg, Placebo 150μg, Placebo 300μg

Alebund Pharmaceuticals

Diabetic Kidney Disease

01/25

NCT06895993: Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants

Not yet recruiting

RoW

Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Injectafer®]

Sichuan Huiyu Pharmaceutical Co., Ltd, Suzhou Guochen Biotechnology Co., Ltd., Guangzhou Jeeyor Medical Research Co.,Ltd., Boji Medical Technology Co., Ltd., The First Hospital of Jilin University

Healthy Adult

04/25

05/25

NCT03806621: Rota China Registry

Completed

N/A

980

RoW

Rotational Atherectomy

Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd.

Coronary Artery Disease

12/20

01/22

UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting

N/A

200

RoW

Drug eluting Balloon

Zhejiang Zylox Medical Device Co., Ltd.

Peripheral Arterial Disease (PAD)

12/22

12/24

NCT05608980: 0.01% Hypochlorous Acid in the Treatment of Blepharitis

Recruiting

N/A

100

RoW

0.01% hypochlorous acid, 0.01%HOCI, Placebo

Eye & ENT Hospital of Fudan University, ShuGuang Hospital

Blepharitis

12/22

05/23

NCT05685966: Retrospective Study of COVID-19 on Reproductive Function

Recruiting

N/A

400

RoW

no intervention

Jinling Hospital, China

COVID-19

03/23

01/24

NCT04852406: Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Recruiting

N/A

526

RoW

Protocol-based management of perioperative antithrombotic therapy, Protocol-based management, Routine management of perioperative antithrombotic therapy, Routine management

Peking University First Hospital

Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes

12/23

01/24

NCT05685992: Novel Coronavirus Infection and Reproductive Function

Recruiting

N/A

400

RoW

no intervention

Jinling Hospital, China

COVID-19 Infection

01/24

CSILS, NCT04527861: Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Recruiting

N/A

710

RoW

Single-incision Laparoscopic Surgery, SILS, Conventional Laparoscopic Surgery, CLS

Colorectal Cancer, Colon Cancer, Rectal Cancer

04/24

04/29

NCT04645810: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Recruiting

N/A

High-Dose-Rate Brachytherapy

University of Rochester

Prostate Cancer, HDR

05/26

05/27

SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis

Recruiting

N/A

328

RoW

Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon

DK Medical Technology (Suzhou) Co., Ltd.

Arteriovenous Fistula Stenosis

07/27

TaLaR, NCT02966483: Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Recruiting

N/A

1114

RoW

TaTME, Transanal TME, LpTME, Laparoscopic TME

Rectal Neoplasms Malignant, Surgery

07/26

mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting

N/A

10000

RoW

Installation or registration of smartphone application

Chinese Alliance Against Lung Cancer

Solitary Pulmonary Nodule

10/25

NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting

N/A

2150

RoW

Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy

Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Heart Disease

01/26

01/28

FLORA-01, NCT05730595: Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Not yet recruiting

N/A

550

RoW

lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer

Colorectal Neoplasms, Fluorescence, Lymph Node Excision

12/26

06/27

TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting

N/A

366

Canada, RoW

The George Institute, Peking University Institute of Nephrology

IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases

07/27

coordinator

NCT05070455: An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Recruiting

Asceniv™

ADMA Biologics, Inc.

Primary Immune Deficiency

03/23

06/23

NCT06923891: An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients

Not yet recruiting

172

Xanomeline/Trospium, Cobenfy

Vanguard Research Group, Bristol-Myers Squibb

Schizophrenia

10/26

11/26

VRDN-001-302, NCT06179875: An Open-label Study for Non-responders of VRDN-001-101 and VRDN-001-301 (OLE)

Active, not recruiting

143

Europe, US, RoW

Intervention/Treatment

Viridian Therapeutics, Inc.

Thyroid Eye Disease

05/25

07/25

RECOVER, NCT05184335: Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Recruiting

690

Brilaroxazine, RP5063, Placebo

Reviva Pharmaceuticals

Schizophrenia

02/25

STRIVE, NCT06384547: A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants with Thyroid Eye Disease (TED)

Active, not recruiting

231

Europe, US, RoW

VRDN-001 10 mg/kg, VRDN-001 3 mg/kg

Viridian Therapeutics, Inc.

Thyroid Eye Disease

05/25

01/26

REVEAL-1, NCT06625411: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Active Thyroid Eye Disease (TED)

Recruiting

117

VRDN-003, Placebo

Viridian Therapeutics, Inc.

Thyroid Eye Disease

03/26

11/26

REVEAL-2, NCT06625398: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Chronic Thyroid Eye Disease (TED)

Recruiting

195

VRDN-003, Placebo

Viridian Therapeutics, Inc.

Thyroid Eye Disease

04/26

12/26

THRIVE-2, NCT06021054: An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Active, not recruiting

188

Europe, US, RoW

Veligrotug (VRDN-001), Placebo

Viridian Therapeutics, Inc.

Thyroid Eye Disease

12/24

08/25

NCT04222062: A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Recruiting

100

Carmustine 7.7Mg Wafer, GLIADEL

University of Nebraska, Arbor Pharmaceuticals, Inc.

Brain Tumor - Metastatic

12/27

12/28

NCT06107686: A Study of YL202 in Selected Patients with Advanced Solid Tumors

Recruiting

200

RoW

YL202 should be intravenously infused

MediLink Therapeutics (Suzhou) Co., Ltd.

NSCLC, Breast Cancer, HNSCC, Locally Advanced or Metastatic Solid Tumors

11/26

11/28

NCT06057922: A Study YL201 in Patients With Selected Advanced Solid Tumors

Recruiting

1/2

990

RoW

YL201 for Injection

MediLink Therapeutics (Suzhou) Co., Ltd.

Advanced Solid Tumor

10/26

10/28

BLAAC PD, NCT06719583: Black and African Americans Connections to Parkinson's Disease

Recruiting

N/A

2000

Parkinson Disease

12/26

NCT06186596: Self-Administered Intralesional Injections for Acne

Recruiting

N/A

150

Triamcinolone delivered via injection assistance device

ACOM Labs

Acne Vulgaris

01/24

NCT05879198: Train Your Brain: A Pilot Project to Improve Memory and Decision Making

Completed

N/A

Computer-based Intervention

Henry Ford Health System, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Behavior, Health

09/23

Recruiting

N/A

1410

Aqtual, Inc.

Rheumatoid Arthritis

06/25

12/25

NCT04642898: Increasing Treatment Efficacy Using SMART Methods for Personalizing Care

Completed

N/A

Standard UP Treatment, Capitalization UP Treatment, Compensation UP Treatment

Shannon E. Sauer-Zavala, National Institute of Mental Health (NIMH)

Anxiety Disorders, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder

06/24

NCT03594994: Metabolic Effects of Sleep Extension in People With Obesity

Completed

N/A

Sleep extension

Washington University School of Medicine

Insulin Resistance, Obesity

07/24

NCT06242704: Train Your Brain 2.0 - Improving Memory and Decision Making Among Youth

Recruiting

N/A

Working Memory Training, Working Memory

Henry Ford Health System

Behavior, Health

08/26

NCT04587518: Five Factor Model Treatment for Borderline Personality Disorder

Completed

N/A

100

Personality-Based Cognitive Behavioral Therapy

Shannon E. Sauer-Zavala

Borderline Personality Disorder

05/24

NCT05100836: SURPASS Impella 5.5 Study

Active, not recruiting

N/A

1017

Impella 5.5

Abiomed Inc.

Cardiogenic Shock, Acute Decompensated Heart Failure

03/25

ELEVATE-HF, NCT06592508: Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure

Recruiting

N/A

180

Remote Virtual Cardiology Program

Duke University, Ventricle Health

Heart Failure; With Decompensation

08/26

NCT03701828: Liver Health and Metabolic Function in People With Obesity

Completed

N/A

Weight loss surgery, Sleeve gastrectomy, Roux-en-Y, biliopancreatic diversion

Washington University School of Medicine

Non-Alcoholic Fatty Liver Disease

02/24

PsOWell, NCT05631223: Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)

Recruiting

N/A

Telemedicine

University of Pennsylvania

Psoriatic Arthritis

12/25

EIR, NCT05489133: Early Psychological Intervention After Rape

Recruiting

N/A

200

Europe

Modified prolonged exposure, Brief intervention, cognitive behavioral therapy

05/25

12/27

CHOICES3, NCT05292781: Sickle Cell Disease Parenting CHOICES

Recruiting

N/A

506

CHOICES, eBook

University of Florida, National Human Genome Research Institute (NHGRI)

Sickle Cell Disease, Sickle Cell Trait

06/25

EXTEND, NCT05120544: Expanding Technology-Enabled Nurse Delivered Chronic Disease Care

Active, not recruiting

N/A

220

EXTEND Plus, EXTEND

Duke University, National Institute of Nursing Research (NINR)

Diabetes Mellitus, Type 2, Hypertension

10/25

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites